Lawrence
Rosenberg, M.D., Ph.D. received
his M.D. from McGill University in 1979 and completed surgical training in
General Surgery at the Montreal General Hospital. During his residency, Dr.
Rosenberg completed a Ph.D. in Experimental Surgery at McGill University. He
completed post-doctoral studies, including a transplant surgery fellowship at
the University of Michigan, and in 1987 he was appointed Assistant Professor
of Surgery and Medicine at McGill University. He is currently Professor of
Surgery and Medicine and Director of the Division of Surgical Research at
McGill University, and the A.G. Thompson Chair of Surgical Research at the
McGill University Health Center.
Dr.
Rosenberg’s current studies address islet cell neogenesis, pancreatic stem
cells, and islet cell death and survival. He is the co-discover of INGAP, a
novel pancreatic differentiation factor, presently in clinical trial as a
novel therapy by the in-vivo induction of islet cell neogenesis.
Dr.
Rosenberg has served on grant review panels of the Juvenile Diabetes Research
Foundation (JDRF) and the Canadian Diabetes Association (CDA), and reviews on
an ad hoc basis for NIH study sections. He is a member of the Investigator
Awards Committee of the Canadian Institutes for Health Research (CIHR) and the
College of Electors for Canada Chairs, and was a founding member of the Stem
Cell Network of Canada. He has consulted for several well known pharmaceutical
and biotechnology companies in the areas of pancreatitis, pancreatic cancer,
and cell therapy of diabetes and has developed expertise in issues related to
technology transfer. Dr. Rosenberg is on the editorial boards of Graft and
Pancreatology and is a reviewer for many prestigious journals. He is an author
on more than 250 peer-reviewed publications, book chapters and abstracts. He
has been continuously funded by the Canadian Institutes for Health Research
for almost 15 years. He is currently the PI on several research grants,
including a JDRF Center grant for Beta-Cell Replacement, for which he is the
Director. He is a frequent guest lecturer on issues related to the cellular
therapy of diabetes, including islet cell neogenesis and stem cells, and
pancreatic cell plasticity.
The
contributions of Dr. Rosenberg have been acknowledged by many national and
international agencies including the Juvenile Diabetes Research Foundation
(JDRF), the Canadian Institute of Health Research (CIHR), and the Stem Cell
Network of Canada. In addition, Dr. Rosenberg has received many career awards
and fellowships, including: a Medical Research Council of Canada Fellowship,
McLaughlin Foundation Fellowship, Medical Research Council of Canada
Scholarship, a Senior Clinician-Scientist Award and National Scientist Award
both from the government of Quebec. He is the only Canadian to have been a
recipient of the prestigious American Surgical Association Foundation
Fellowship.
